목차
1. Management of chronic insomnia
2. Advances in the management of chronic insomnia
3. Introduction : Definition
4. Prevalence and Incidence
5. Sources and selection criteria
6. Non-pharmacologic management
7. Computerized and online CBT-I (cCBT-I)
8. CBT-I through telehealth (tCBT-I)
9. Dissemination of CBT-I to non-sleep specialists
10. Individual components
11. Advances in pharmacotherapy for insomnia
12. Controversies over drugs for insomnia
2. Advances in the management of chronic insomnia
3. Introduction : Definition
4. Prevalence and Incidence
5. Sources and selection criteria
6. Non-pharmacologic management
7. Computerized and online CBT-I (cCBT-I)
8. CBT-I through telehealth (tCBT-I)
9. Dissemination of CBT-I to non-sleep specialists
10. Individual components
11. Advances in pharmacotherapy for insomnia
12. Controversies over drugs for insomnia
본문내용
Definition of Chronic insomnia
ICSD-3
(International Classification of Sleep Disorders, Version 3)
Having one of the following problems for
at least 3 days a week, for at least 3 months
Difficulty initiating sleep
Difficulty maintaining sleep
Waking earlier than desired
Resistance to going to bed on appropriate schedule
Difficulty sleeping without a parent or caregiver
▶ CBT-I
(Cognitive behavioral therapy for insomnia)
Efficacy is undiputed
Problems with accessibility and cost effectiveness
No benefit from this treatment
▶ Non-pharmacological alternatives
: Efficacy and shortcomings of
various ways to deliver CBT-I and newer
▶ Newer pharmacological agents
: Controversies surrounding
sedative hypnotic drugs,
evidence about the long term use of
sedative hypnotics
ICSD-3
(International Classification of Sleep Disorders, Version 3)
Having one of the following problems for
at least 3 days a week, for at least 3 months
Difficulty initiating sleep
Difficulty maintaining sleep
Waking earlier than desired
Resistance to going to bed on appropriate schedule
Difficulty sleeping without a parent or caregiver
▶ CBT-I
(Cognitive behavioral therapy for insomnia)
Efficacy is undiputed
Problems with accessibility and cost effectiveness
No benefit from this treatment
▶ Non-pharmacological alternatives
: Efficacy and shortcomings of
various ways to deliver CBT-I and newer
▶ Newer pharmacological agents
: Controversies surrounding
sedative hypnotic drugs,
evidence about the long term use of
sedative hypnotics
추천자료
- ADHD 정의및 원인과 치료(주의력 결핍 과잉행동)
- ADHD 정의,특징,원인분석및 치료및 예방안
- [고위험모아간호학 공통] A.고위험 신생아의 고빌리루빈혈증 사정(진단평가 및 임상증상)과 ...
- [★발표자료★][무용치료와 동작치료] 대상 별 무용치료 방법 - 무용치료의 개념 및 정의와 만...
- [아동정신건강론 兒童精神健康論] 틱장애 (Tic Disorder) - 틱장애의 정의와 원인 및 특징(뚜...
- [감염성 질환] 감염증의 정의, 감염성 질환의 영양 및 치료 식이요법(식사요법), 급성 감염성...
- [ 알코올중독 연구 레포트 ] 알코올중독 정의,특성,원인분석및 알코올중독 문제점과 치료방법...
- [ 불안장애 연구레포트 ] 불안장애 정의,유형,특징및 불안장애 사례분석과 치료법분석및 불안...
- 게임중독 정의,원인,영향분석및 게임중독 문제점과 해결방안,치료사례분석및 게임중독에 대해...
소개글